TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 5,27
arrow_downward
-1,31%(-0,070) 1D
13 nov, 16:00:00 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 5,32
Hoog
US$ 5,32
Laag
US$ 4,95
Beursw.
345,50 mln.
Gem. vol.
294,14K
Volume
287,80K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 5,32
Hoog
US$ 5,32
Laag
US$ 4,95
Beursw.
345,50 mln.
Gem. vol.
294,14K
Volume
287,80K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
Het Financieele Dagblad
·
2 dagen geleden
Pan-Europese Stoxx 600 toont veerkracht, terwijl de Amerikaanse S&P 500 hapert
The Motley Fool
·
33 minuten geleden
Michael Burry's Puts on the Nasdaq-100 Run to April 2027. I'm Not Following Him.
Kalkine
·
3 uur geleden
Black Hawk Acquisition Corporation (NASDAQ: BKHA) Shares Rise 36% as Deal Deadline Approaches
Yahoo Finance Singapore
·
1 uur geleden
Aebi Schmidt Holding (NasdaqGS:AEBI) Stock Fair Value Moves Lower After Soft Q3 And 2026 Cut
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc